Search
Search
Proteintech
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Sequence of this protein is as follows: KTFCEGSPRA QREVSCLQSS RENSHLVTFY GSESHRGHLF VCVTLCEQTL EACLDVHRGE DVENEEDEFA QNVLSSIFKA VQELHLSCGY THQDLQPQNI LIDSKKAAHL ADFDKSIKWA GDPQEVKRDL EDLGRLVLYV VKKGSISFEE LKAQSNEEVV QLSPDEETKD LIHRLFHPGE HVRDCLSDLL GHPFFWTWES RYRTLRNVGN ESDIKTRKSE SEILRLLQPG PSEHSKSFDK WTTKINECVM KKMNKFYEKR GNFYQNTVGD LLKFIRNLGE HIDEEKHKKM KLKIGDPSLY FQKTFPDLVI YVYTKLQNTE YRKHFPQTHS PNKPQCDGAG GASGLASPGC
A virally induced endoribonuclease, RNase L is the terminal factor of the anti-viral action of interferon. Activation of RNase L results in inhibition of viral proliferation. Activation of RNase L has also been determined to degrade RNA, thus, initiating a cellular stress response, inducing apoptosis. Since mutations in RNase L relate to an increased incidence of prostate cancer, the activation of RNase L functions in counteracting prostate cancer, via apoptosis.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: 2',5'-oligoisoadenylate synthetase-dependent; 2-5A-dependent ribonuclease; 2-5A-dependent RNAase; 2-5A-dependent RNase; interferon-induced 2-5A-dependent RNase; Ribonuclease 4; Ribonuclease L; ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent); RNase L
基因别名: E230029I04Rik; PRCA1; RNASEL; RNS4
UniProt ID: (Human) Q05823, (Mouse) Q05921
Entrez Gene ID: (Human) 6041, (Mouse) 24014